Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub-analysis of the DIVERSITY-CVR study.

Kota Takuma,Ayako Fuchigami,Fumika Shigiyama,Naoki Kumashiro,Takahisa Hirose

Diabetes, obesity & metabolism（2023）

引用 0|浏览5

暂无评分

摘要

In Japanese patients with early-stage type 2 diabetes, sitagliptin was associated with improved TIR in patients with a lower BMI. Dapagliflozin was effective in patients with a higher BMI. This article is protected by copyright. All rights reserved.

查看译文

关键词

antidiabetic drug, continuous glucose monitoring (CGM), dapagliflozin, sitagliptin, type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要